Dr. Mehmet Oz on Fixing American Healthcare + Fraud | Live from Davos
What this video covers
The All-In Podcast interviews CMS Administrator Dr. Mehmet Oz live from Davos in January 2026, in a wide-ranging conversation about why he left television and surgery for government, how the Trump administration’s pace compares to private-sector “shipping,” and what he is trying to change inside the federal health programs. Oz calls the CMS job “the best job I’ve ever had” and urges people who want change to “take some big swings,” accepting that they will break things occasionally.
The policy core of the interview is the administration’s GLP-1 strategy and his fraud agenda. Oz describes the pricing agreements reached with Novo Nordisk and Eli Lilly ahead of the TrumpRx launch: cash-pay prices he calls completely affordable, a $50 co-pay for every Medicare patient, and no out-of-pocket cost for Medicaid patients โ access he contrasts with the pre-deal geography of weight-loss drugs, where he says the number-one ZIP code for use was Manhattan’s Upper East Side and the second was Los Angeles, because at roughly $1,200 a month only the affluent could pay. He argues the equity stakes are mortal: life expectancy in rural and vulnerable populations, he says, runs about nine years shorter. On the science, he traces GLP-1 drugs to a venom-derived compound acting on the appetite system, says newer drugs will go further โ including on addictive behavior โ and argues the next discovery wave should be implemented the way the President implemented this one. Throughout, he returns to fraud and AI as the agency’s other levers: using technology against criminal billing networks and administrative burden alike.
Key points
- Oz calls CMS “the best job I’ve ever had,” framing his move from TV and surgery as joining “the change business” and urging big swings over consensus-paced reform.
- Oz describes the Novo Nordisk and Eli Lilly pricing agreements behind TrumpRx: affordable cash-pay prices, $50 co-pays in Medicare, and zero out-of-pocket cost in Medicaid.
- Before the deals, he says, the top ZIP codes for weight-loss-drug use were the Upper East Side of Manhattan and Los Angeles โ at about $1,200 a month, access tracked wealth, not need.
- Oz says life expectancy in rural and vulnerable populations is roughly nine years shorter than in affluent areas, and frames GLP-1 access as an equity intervention.
- He traces GLP-1s to a venom-derived compound acting on the appetite system and predicts successor drugs will also reduce addictive behavior.
- Oz presents fraud enforcement and AI as CMS’s parallel agenda: technology to catch criminal billing and to strip administrative burden from clinicians.
The Weekly Scoreboard
Every Friday: what the RFK Jr. HHS team did this week — wins, setbacks, warnings — sourced and linked. Free.